Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma, Newly Diagnosed

Explore clinical trials studying Multiple Myeloma, Newly Diagnosed. Study availability and eligibility vary by location and protocol.

7 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma, Newly Diagnosed trial results

Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

NCT06974786

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • University of Iowa Iowa City, Iowa, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
View Trial Details
Recruiting

Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of Care After D-VRd Induction in Transplant-eligible NDMM Patients

NCT06918002

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • CHU Amiens Amiens, France
  • CHU Angers Angers, France
  • Ch Annecy Genevois Annecy, France
  • Centre Hospitalier d'Argenteuil Victor Dupouy Argenteuil, France
View all 64 locations
View Trial Details
Recruiting

KPD Consolidation After ASCT in NDMM Patients

NCT06879379

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Peking University People's Hospital Beijing, Beijing Municipality, China
  • Fuxing Hospital affiliated to Capital Medical University Beijing, Beijing Municipality, China
  • Shanghai Changzheng Hospital Shanghai, Shanghai Municipality, China
View Trial Details

Related conditions